Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global Stroke Diagnostics and Therapeutics Market, 2015 - 2021 (USD Billion)

2.2. Global Stroke Diagnostics and Therapeutics Market: Snapshot

Chapter 3. Stroke Diagnostics and Therapeutics  Market Dynamics


3.1. Introduction

3.2. Value Chain Analysis

3.3. Market Drivers


3.3.1. Global Stroke Diagnostics and Therapeutics Market Drivers: Impact Analysis

3.3.2. Large Patient Pool Along With Rising Aging Population

3.3.3. Rising Incidences Of Diabetes And Large Number Of Tobacco Users

3.4. Market Restraints


3.4.1. Global Stroke Diagnostics and Therapeutics Market Restraints: Impact Analysis

3.4.2. High Cost Of Treatment

3.4.3. Lack Of Transparent Reimbursement

3.5. Opportunities


3.5.1. Covering Untapped Market

3.6. Porters Five Forces Analysis


3.6.1. Bargaining Power Of Suppliers

3.6.2. Bargaining Power Of Buyers

3.6.3. Threat From New Entrants

3.6.4. Threat From New Substitutes

3.6.5. Degree Of Competition

3.7. Market Attractiveness Analysis


3.7.1. Market Attractiveness Analysis, By Diagnostics Segment

3.7.2. Market Attractiveness Analysis, By Therapeutics Segment

3.7.3. Market Attractiveness Analysis, By Application Segment

3.7.4. Market Attractiveness Analysis, By Regional Segment

Chapter 4. Global Stroke Diagnostics and Therapeutics Market  Competitive Landscape


4.1. Company Market Share, 2015 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Type Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Regional Expansion

4.3. Type Portfolio

Chapter 5. Global Stroke Diagnostics and Therapeutics Market  Diagnostics Analysis


5.1. Global Stroke Diagnostics and Therapeutics Market: Diagnostics Segment Overview


5.1.1. Global Stroke Diagnostics and Therapeutics Market Revenue Share, By Diagnostics, 2015 And 2021

5.2. Magnetic Resonance Imaging


5.2.1. Global Magnetic Resonance Imaging Market, 2015  2021 (USD Billion)

5.3. Computed Tomography Scan


5.3.1. Global Computed Tomography Scan Market, 2015  2021 (USD Billion)

5.4. Electrocardiography


5.4.1. Global Electrocardiography Market, 2015  2021 (USD Billion)

5.5. Carotid Ultrasound


5.5.1. Global Carotid Ultrasound Market, 2015  2021 (USD Billion)

5.6. Cerebral Angiography


5.6.1. Global Cerebral Angiography Market, 2015  2021 (USD Billion)

5.7. Others


5.7.1.Global Others Market, 2015  2021 (USD Billion)

Chapter 6. Global Stroke Diagnostics and Therapeutics Market  Therapeutics Segment Analysis


6.1. Global Stroke Diagnostics and Therapeutics Market: Therapeutics Segment Overview


6.1.1. Global Stroke Diagnostics and Therapeutics Market Revenue Share, By Therapeutics, 2015 And 2021

6.2. Tissue Plasminogen Activator


6.2.1. Global Stroke Diagnostics and Therapeutics Market For Tissue Plasminogen Activator, 2015  2021 (USD Billion)

6.3. Antiplatelet


6.3.1. Global Stroke Diagnostics and Therapeutics Market for Antiplatelet, 2015  2021 (USD Billion)

6.4. Antihypertensive


6.4.1. Global Stroke Diagnostics and Therapeutics Market for Antihypertensive, 2015  2021 (USD Billion)

6.5. Anticoagulant


6.5.1. Global Stroke Diagnostics and Therapeutics Market for Anticoagulant, 2015  2021 (USD Billion)

Chapter 7. Global Stroke Diagnostics and Therapeutics Market  Application Segment Analysis


7.1. Global Stroke Diagnostics and Therapeutics Market: Application Segment Overview


7.1.1. Global Stroke Diagnostics and Therapeutics Market Revenue Share, By Application, 2015 And 2021

7.2. Haemorrhagic Stroke


7.2.1. Global Stroke Diagnostics and Therapeutics Market For Haemorrhagic Stroke , 2015  2021 (USD Billion)

7.3. Ischemic Stroke


7.3.1. Global Stroke Diagnostics and Therapeutics Market for Ischemic Stroke, 2015  2021 (USD Billion)

Chapter 8. Global Stroke Diagnostics and Therapeutics Market  Regional Segment Analysis


8.1. Global Stroke Diagnostics and Therapeutics Market: Regional Overview


8.1.1. Global Stroke Diagnostics and Therapeutics Market Revenue Share, By Region, 2015 And 2021

8.2. North America


8.2.1. North America Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 , (USD Billion)

8.2.2. North America Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 , (USD Billion)

8.2.3. North America Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 , (USD Billion)

8.2.4. U.S.


8.2.4.1. U.S. Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.2.5. U.S.


8.2.5.1. U.S. Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.2.6. U.S.


8.2.6.1. U.S. Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

8.3. Europe


8.3.1. Europe Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.3.2. Europe Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.3.3. Europe Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

8.3.4. Germany


8.3.4.1. Germany Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021, (USD Billion)

8.3.4.2. Germany Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021, (USD Billion)

8.3.4.3. Germany Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021, (USD Billion)

8.3.5. France


8.3.5.1. France Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021, (USD Billion)

8.3.5.2. France Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021, (USD Billion)

8.3.5.3. France Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021, (USD Billion)

8.3.6. U.K.


8.3.6.1. U.K. Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.3.6.2. U.K. Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.3.6.3. U.K. Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

8.4. Asia Pacific


8.4.1. Asia Pacific Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.4.2. Asia Pacific Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.4.3. Asia Pacific Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

8.4.4. China


8.4.4.1. China Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.4.4.2. China Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.4.4.3. China Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

8.4.5. Japan


8.4.5.1. Japan Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.4.5.2. Japan Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.4.5.3. Japan Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

8.4.6. India


8.4.6.1. India Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.4.6.2. India Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.4.6.3. India Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

8.5. Latin America


8.5.1. Latin America Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.5.2. Latin America Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.5.3. Latin America Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

8.5.4. Brazil


8.5.4.1. Brazil Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.5.4.2. Brazil Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.5.4.3. Brazil Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

8.6. Middle East And Africa


8.6.1. Middle East And Africa Stroke Diagnostics and Therapeutics Market Revenue, By Diagnostics, 2015  2021 (USD Billion)

8.6.2. Middle East And Africa Stroke Diagnostics and Therapeutics Market Revenue, By Therapeutics, 2015  2021 (USD Billion)

8.6.3. Middle East And Africa Stroke Diagnostics and Therapeutics Market Revenue, By Application, 2015  2021 (USD Billion)

Chapter 9. Company Profile


9.1. Abbott Laboratories,


9.1.1. Overview

9.1.2. Financials

9.1.3. Product Portfolio

9.1.4. Business Strategy

9.1.5. Recent Developments

9.2. Medtronic plc,


9.2.1. Overview

9.2.2. Financials

9.2.3. Product Portfolio

9.2.4. Business Strategy

9.2.5. Recent Developments

9.3. Boston Scientific Corporation,


9.3.1. Overview

9.3.2. Financials

9.3.3. Product Portfolio

9.3.4. Business Strategy

9.3.5. Recent Developments

9.4. Cordis Corporation,


9.4.1. Overview

9.4.2. Financials

9.4.3. Product Portfolio

9.4.4. Business Strategy

9.4.5. Recent Developments

9.5. Koninklijke Philips N.V.,


9.5.1. Overview

9.5.2. Financials

9.5.3. Product Portfolio

9.5.4. Business Strategy

9.5.5. Recent Developments

9.6. GE Healthcare,.


9.6.1. Overview

9.6.2. Financials

9.6.3. Product Portfolio

9.6.4. Business Strategy

9.6.5. Recent Developments

9.7. Siemens AG


9.7.1. Overview

9.7.2. Financials

9.7.3. Product Portfolio

9.7.4. Business Strategy

9.7.5. Recent Developments

9.8. Stryker Corporation


9.8.1. Overview

9.8.2. Financials

9.8.3. Product Portfolio

9.8.4. Business Strategy

9.8.5. Recent Developments

9.9. Merck  Co., Inc.


9.9.1. Overview

9.9.2. Financials

9.9.3. Product Portfolio

9.9.4. Business Strategy

9.9.5. Recent Developments